Category Archives: Business and Investments

Latest From Business and Investments

Therapeutic Licensing and M&A Deals

lab_tech

Licensing deals for therapeutic candidates in 2013 dropped to the lowest volume in at least eight years for deals with disclosed values totaling over $10M. Total upfront payments to biotechs were also at an eight year low, with only $1.9B paid to biotechs in 2013. This is a 50 percent drop from peak levels. However, there is a silver lining in the data: Preclinical deal volume saw a slight increase in 2013, and has not Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , ,

New Type of Prospective Survey Initiative

scientist-eyedropper

Our industry is on the cutting-edge of science aimed at developing new therapies for devastating and life-threatening diseases. To help advance innovation and promote the development of the next generation of treatments and cures, we must acknowledge that the scientific method does not operate in a vacuum. Robust, interactive FDA-Sponsor communication is a key element of modern drug development. However, in order to improve the drug development enterprise and the FDA review process further, the Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Technology Transfer: Making A Better World

Jane_Muir_bio_photo-1

As our dear friend, the late Howard Bremer was so fond of saying, the underlying principle of what we do is “bringing research discoveries to the market to improve the human condition.” Technology transfer is a relatively young profession. Just a few years ago most people had never heard about it. Today, more than 30 years after the passage of the Bayh-Dole Act, more eyes than ever before are focused on us and our efforts. Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , ,

Maximize Your Savings and Winning Potential during the BIO International Convention

pig-bank

$135,000,000. That’s how much BIO saved life science companies in aggregate on their 2013 purchases of products and services. More than 2,800 companies nationwide participate in the industry’s largest cost savings program known as BIO Business Solutions®, by taking advantage of the program’s preferential pricing and other benefits. Find out how your company can save money and become a partaker by stopping by the BIO Partner Pavilion (Booth #4317) during the convention. The BIO Partner Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , ,

Debunking the Biotech Bubble Talk

Chart

The Nasdaq Biotechnology Index (NBI) has been on a wild ride in 2014 with a 20 percent gain in the first two months, a 24 percent drop from late February to mid-April, and a rebound of 16 percent off April lows by early June. This recent sell-off follows a 130 percent gain over the last three years and the debut of 100 biotech IPOs, leading some investors to ask if the recent sell-off is the Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , ,